Moreover, renal inflammation and injuries caused by bacterial endotoxemia could be prevented by injecting lysophosphatidic acid (LPA), the product of LysoPC hydrolysis by the lysophospholipase D (also named ATX) (Mirzoyan et al., 2017). The gene discussed is ENPP2; the disease is inflammatory response.